Colgate-Palmolive stock steadies around $92 as Q2 2026 margins lag sales growth
Published on 08/27/2026 at 18:47 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Colgate-Palmolive (ISIN US1941621039) stock is trading in a tight band around $92 on the New York Stock Exchange as of late August 2026, with recent data showing intraday levels near $92.12 and a prior close at $92.06 on August 26, 2026.
Recent earnings coverage for the June quarter of 2026 indicates that Colgate-Palmolive delivered net sales of $5.361 billion in the second quarter of 2026, up from $5.11 billion in the same period of 2025, while operating profit and net income declined year over year even as revenue advanced.
Consensus data compiled in late August 2026 point to a moderate buy stance on Colgate-Palmolive stock, with an average price target of $99.00 against a recent closing price of $91.33 on August 25, 2026, implying a single-digit percentage upside if the company meets current expectations.
Q2 2026 sales rise but margins slip
Per a recent second-quarter 2026 earnings summary, Colgate-Palmolive reported net sales of $5.361 billion in Q2 2026, which compares with $5.11 billion in the second quarter of 2025 and highlights year-over-year top-line growth of roughly 4.9 percent for the period. The same report notes that operating profit reached $1.016 billion in Q2 2026, down from $1.08 billion a year earlier, underscoring that profitability compressed despite the higher sales base.
The earnings overview also indicates that net income attributable to Colgate-Palmolive fell to $693 million in the second quarter of 2026 from $743 million in the second quarter of 2025, reinforcing that earnings contracted even as revenue increased. The report frames this development against an environment of input cost pressures and competitive dynamics in key categories.
A separate analysis of Colgate-Palmolive’s second-quarter 2026 performance highlights that worldwide organic volume grew for the third consecutive quarter, accompanied by wider margins and stronger free cash flow, even as certain segments and regions faced a difficult operating backdrop. This discussion emphasizes that continued volume gains alongside pricing actions are central to the company’s effort to sustain growth.
Guidance and analyst expectations
Commentary on Colgate-Palmolive’s July 2026 communication notes that management reaffirmed its full-year 2026 outlook, targeting net sales growth of 2 percent to 6 percent and double-digit GAAP earnings per share growth. The same source argues that maintaining this guidance after Q2 2026 results suggests leadership sees the recent mix of higher volumes, pricing initiatives, and margin changes as consistent with the existing plan rather than as a reason to reset expectations.
Late-August 2026 consensus data compiled in an earnings and ratings overview show that analysts collectively assign a moderate buy rating to Colgate-Palmolive stock, with an average price target of $99.00. That overview contrasts the $99.00 target with a closing price of $91.33 on August 25, 2026, indicating that the target sits $7.67 above that close, which translates into an indicated upside of slightly more than 8 percent if the shares were to move in line with the consensus valuation.
Additional market commentary notes that Colgate-Palmolive stock trades on the New York Stock Exchange under the ticker CL and that recent price action has clustered in a narrow range from roughly $90 to $92 as of late August 2026. The same piece cites a last price of $92.11 as of August 26, 2026, 11:44 a.m. Eastern Time, marking a 0.85 percent gain for that session, and also records an intraday reading of $91.72 at 12:34 p.m. Eastern Time with the price down 0.90 percent, underscoring how the stock fluctuated within a relatively tight band.
Go deeper
Further coverage of Colgate-Palmolive’s Q2 2026 numbers and guidance trends can be found in the earnings analysis that details revenue growth, margin movements, and free cash flow dynamics as management balances pricing and volume initiatives with raw material and foreign-exchange headwinds.
Read more
More on Colgate-Palmolive stock and its latest investor communications is available through the company’s investor relations portal, including webcasts and releases that discuss strategic priorities and upcoming conference appearances.
Oral care brands support the franchise
Colgate-Palmolive’s core business is built around oral care, personal care, and home care products, and the Colgate toothpaste franchise remains one of the company’s most recognizable offerings worldwide. Recent strategic commentary on Colgate-Palmolive’s long-term growth story underscores the importance of sustaining brand strength in oral care through innovation and marketing, as the company continues to compete in both developed and emerging markets where demographic and income trends support demand.
In addition to toothpaste, Colgate-Palmolive’s oral care portfolio includes toothbrushes and mouthwashes positioned across value and premium segments, which allows the company to address different price points while maintaining scale benefits in manufacturing and distribution. This product lineup ties into the broader strategy of pursuing modest but steady net sales growth while working to protect margins through efficiency programs and selective price moves.
Colgate-Palmolive stock and recent trading levels
Fact-based trading data show that Colgate-Palmolive stock closed at $91.33 on the New York Stock Exchange on August 25, 2026, providing a clear reference for the share price close to the current period. The same snapshot indicates that the shares were expected to open at $91.27 in subsequent trading, reinforcing the picture of a relatively stable price near the low-$90s.
Market overview pages covering Colgate-Palmolive stock also list a last price of $92.06 at the close of August 26, 2026, and intraday quotes around $92.11 as of late morning Eastern Time that day, each in United States dollars. One such page presents $92.06 as the most recent closing price, alongside an average target price of $98.95, which is in line with other summaries that cite a $99.00 consensus target, illustrating that the current market price remains below the typical analyst valuation range.
Fact box
Company: Colgate-Palmolive Company
ISIN: US1941621039
Ticker: CL
Exchange: New York Stock Exchange
Price (as of August 26, 2026, 4:00 p.m. ET): $92.06 USD
Market cap: not specified in available sources
Sector / Industry: Consumer staples / Household and personal care
Index membership: S&P 500
